Categories: News

Paubox Leads G2 Grid® Fall 2021

SAN FRANSISCO, Sept. 14, 2021 /PRNewswire/ — Paubox continues to lead the HIPAA compliant email industry in several categories of the G2 Grid® Fall 2021 Report, including HIPAA Compliant Messaging, Secure Email Gateway, Email Security, and Email Encryption.

Paubox tops all HIPAA compliant messaging software vendors in total customer reviews on G2 with 170 reviews, 90% more than its nearest competitor. Paubox also has a G2 score of 4.9 out of 5 stars.

Paubox also earned G2 badges for:

  • Momentum Leader
  • Leader
  • Easiest Setup
  • Highest User Adoption
  • Most Implementable
  • Best Support
  • Easiest To Do Business With
  • Best Relationship
  • Best Results
  • Users Most Likely To Recommend
  • Easiest Admin
  • Easiest To Use
  • Best Meets Requirements
  • Best Usability
  • Users Love Us

“Continued recognition from G2 reinforces our leadership position in the HIPAA compliant email space,” said Hoala Greevy, Founder CEO of Paubox. “We will continue to focus on providing our customers with secure, reliable, and easy to use secure email.”

Additional Resources:

Website, Blog & Social Networks:

About Paubox

Paubox provides secure email for modern healthcare. Right out of the box. Offering HITRUST CSF certified solutions, customers can trust Paubox to provide them with seamless, secure, HIPAA compliant email products.

Contact:

Cailin Pitcher
press@paubox.com
415-795-7396

View original content:https://www.prnewswire.com/news-releases/paubox-leads-g2-grid-fall-2021-301376221.html

SOURCE Paubox

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

1 day ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

2 days ago